Financials

  • Market Capitalization 4.05 M
  • Employee 4
  • Founded 2015
  • CEO Manuel Litchman
  • Website www.mustangbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00FXTN420
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4983
HCWB
HCW Biologics Inc. - Common Stock
2.27 USD+4.13%-12.36%-14.98%+268.51%4.17 M USD
4986
SILO
Silo Pharma Inc -, effectuated 1:50 R/S on 9/15
2.61 USD-1.51%-17.14%-42.51%+314.29%4.15 M USD
4997
GRI
GRI Bio, Inc. - Common Stock
1.82 USD+10.30%+7.06%+29.08%-31.32%3.98 M USD
4998
CLGN
CollPlant Biotechnologies Ltd. - Ordinary Shares
0.31 USD0.00%-3.13%-8.82%-88.03%3.97 M USD

Frequently asked questions about Mustang Bio, Inc.

What is the Mustang Bio, Inc. stock price today?

The current price of Mustang Bio, Inc. (MBIO) is 0.56. Over the past 24 hours, the stock has changed by -3.45%. Follow the MBIO chart for real-time price dynamics.

What is the stock ticker of Mustang Bio, Inc.?

Mustang Bio, Inc. trades under the ticker MBIO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Mustang Bio, Inc. stock going up?

MBIO has changed by -5.08% over the last week, -1.75% over the last month, and -35.48% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Mustang Bio, Inc.?

Mustang Bio, Inc. currently has a market capitalization of 4.05 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Mustang Bio, Inc. earnings last quarter?

Last quarter, Mustang Bio, Inc. reported earnings of -0.16 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Mustang Bio, Inc. net income for the last quarter?

Mustang Bio, Inc. reported net income of -1.07 M for the last quarter. The previous quarter showed -955 K, which means net income changed by -12.25%.

How many employees does Mustang Bio, Inc. have?

As of the latest available data, Mustang Bio, Inc. has 4 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Mustang Bio, Inc. stock?

You can buy Mustang Bio, Inc. (MBIO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Mustang Bio, Inc. stock?

Investing in Mustang Bio, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MBIO chart and related analysis on metatrader.com as part of your research.

Mustang Bio, Inc. - Common Stock

Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency.

News